Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACIN1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | CBLN2 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | TCEAL5 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | EMC7 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | CTSZ | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | ENHO | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | LRRC4C | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | GPR162 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | TMOD2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |